572 related articles for article (PubMed ID: 27989748)
21. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
22. Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells.
Gao X; Han H
J Cell Biochem; 2018 Jun; 119(6):4967-4974. PubMed ID: 29384225
[TBL] [Abstract][Full Text] [Related]
23. Artocarpin, an isoprenyl flavonoid, induces p53-dependent or independent apoptosis via ROS-mediated MAPKs and Akt activation in non-small cell lung cancer cells.
Tsai MH; Liu JF; Chiang YC; Hu SC; Hsu LF; Lin YC; Lin ZC; Lee HC; Chen MC; Huang CL; Lee CW
Oncotarget; 2017 Apr; 8(17):28342-28358. PubMed ID: 28423703
[TBL] [Abstract][Full Text] [Related]
24. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.
Liu X; Li J; Huang Q; Jin M; Huang G
Mol Med; 2024 Apr; 30(1):56. PubMed ID: 38671369
[TBL] [Abstract][Full Text] [Related]
25. Circ_0017639 facilitates proliferative, migratory, and invasive potential of non-small cell lung cancer (NSCLC) cells via PI3K/AKT signaling pathway.
Zhang HB; Qiu XM; Zhang YC; Huang TT; Zuo ZJ; Zhang T
Bioengineered; 2022 Jan; 13(1):1590-1601. PubMed ID: 35000535
[TBL] [Abstract][Full Text] [Related]
26. Consumption of S-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model.
Tang FY; Chiang EP; Pai MH
J Agric Food Chem; 2010 Oct; 58(20):11156-64. PubMed ID: 20866043
[TBL] [Abstract][Full Text] [Related]
27. NOX4-Derived ROS Mediates TGF-
Su X; Yang Y; Guo C; Zhang R; Sun S; Wang Y; Qiao Q; Fu Y; Pang Q
Oxid Med Cell Longev; 2021; 2021():5549047. PubMed ID: 34257808
[TBL] [Abstract][Full Text] [Related]
28. MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway.
Sun DM; Tang BF; Li ZX; Guo HB; Cheng JL; Song PP; Zhao X
Sci Rep; 2018 May; 8(1):8007. PubMed ID: 29789623
[TBL] [Abstract][Full Text] [Related]
29. Fangchinoline inhibits non-small cell lung cancer metastasis by reversing epithelial-mesenchymal transition and suppressing the cytosolic ROS-related Akt-mTOR signaling pathway.
Chen B; Song Y; Zhan Y; Zhou S; Ke J; Ao W; Zhang Y; Liang Q; He M; Li S; Xie F; Huang H; Chan WN; Cheung AHK; Ma BBY; Kang W; To KF; Xiao J
Cancer Lett; 2022 Sep; 543():215783. PubMed ID: 35700820
[TBL] [Abstract][Full Text] [Related]
30. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
31. Luteoloside induces G
Zhou M; Shen S; Zhao X; Gong X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
[TBL] [Abstract][Full Text] [Related]
32. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.
Liu XX; Xiong HP; Huang JS; Qi K; Xu JJ
Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):895-902. PubMed ID: 28477368
[TBL] [Abstract][Full Text] [Related]
33. Glutathione Peroxidase 1 Promotes NSCLC Resistance to Cisplatin via ROS-Induced Activation of PI3K/AKT Pathway.
Chen B; Shen Z; Wu D; Xie X; Xu X; Lv L; Dai H; Chen J; Gan X
Biomed Res Int; 2019; 2019():7640547. PubMed ID: 31032363
[TBL] [Abstract][Full Text] [Related]
34. Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-κB Signaling Pathway in Vitro and in Vivo.
Zhou B; Wang D; Sun G; Mei F; Cui Y; Xu H
Cell Physiol Biochem; 2018; 46(3):999-1008. PubMed ID: 29669316
[TBL] [Abstract][Full Text] [Related]
35. Juglone triggers apoptosis of non-small cell lung cancer through the reactive oxygen species -mediated PI3K/Akt pathway.
Zhong J; Hua Y; Zou S; Wang B
PLoS One; 2024; 19(5):e0299921. PubMed ID: 38814975
[TBL] [Abstract][Full Text] [Related]
36. The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer.
Dong C; Chen Y; Li H; Yang Y; Zhang H; Ke K; Shi XN; Liu X; Li L; Ma J; Kung HF; Chen C; Lin MC
Int J Biol Sci; 2019; 15(7):1523-1532. PubMed ID: 31337981
[No Abstract] [Full Text] [Related]
37. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway.
Yin Y; Sui C; Meng F; Ma P; Jiang Y
Lipids Health Dis; 2017 May; 16(1):87. PubMed ID: 28468627
[TBL] [Abstract][Full Text] [Related]
38. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
[TBL] [Abstract][Full Text] [Related]
39. A novel small-molecule PI3K/Akt signaling inhibitor, W934, exhibits potent antitumor efficacy in A549 non-small-cell lung cancer.
Wang J; Wang HY; Shen Y; Liang D; Wang HY; Zhang SQ; Cao YX; Cao L
Anticancer Drugs; 2019 Oct; 30(9):900-908. PubMed ID: 30913062
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA DDX11-AS1 promotes non-small cell lung cancer development via regulating PI3K/AKT signalling.
Feng X; Yang S; Zhou S; Deng S; Xie Y
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1622-1631. PubMed ID: 32298476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]